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ABSTRACT
InTRoduCTIon: Patients with bronchiectasis suffer from 
breathlessness, cough and sputum production, which 
impairs quality of life. The Bronchiectasis Health 
Questionnaire (BHQ), a short and disease-specific 
questionnaire, has previously been developed and validated 
in English. The aim of this study was to translate and 
validate the BHQ in Danish, using established cross-cultural 
validation methods.
MeThodS: To create a Danish version of the questionnaire, 
this study used linguistic validation, a pilot study in 17 
patients and forward-backward translation. Thereafter, 111 
patients with bronchiectasis were asked to complete the 
BHQ (BHQ1) as well as the St George Respiratory 
Questionnaire (SGRQ), and one in three patients were asked 
to repeat the BHQ after two weeks had passed (BHQ2).
ReSulTS: There was a significant convergent validity 
between the BHQ1 and the SGRQ (ρ = –0,826, p = 0.0001), a 
satisfactory correlation coefficient between the BHQ1 and 
the BHQ2 (0.739) and a lower limit of agreement of –15.96 
and 20.56 in the Bland Altmann plot.
ConCluSIonS: The BHQ is translated and validated in 
Danish and retains good validity properties. This 
questionnaire is ready for use in daily clinical practice 
among Danish-speaking patients.
FundIng: none. 
TRIAl RegISTRATIon: not relevant.
 
Bronchiectasis is a persistent, potentially progressive, 
condition, characterised by dilated bronchi [1]. The 
clinical presentation of bronchiectasis includes breath-
lessness, cough, sputum production and haemoptysis. 
The severity of bronchiectasis can be assessed using 
composite scores like the Bronchiectasis Severity Index 
and the FACED score [2-4], which combines physiolog-
ical and radiological measures. However, the complex 
patient-perceived sense of well-being is not truly cap-
tured by physiological measures only. Health-related 
quality of life (HRQoL), defined as “the perception of 
the impact of health on an individual’s contentment or 
satisfaction with life in areas they consider important” 
[5], is a relatively simple way to achieve a comprehen-
sive measure of this otherwise diffuse dimension. In 
bronchiectasis, HRQoL has been shown to be nega-
tively associated with mortality and with the number of 
disease comorbidities [6, 7].
A number of HrQoL questionnaires are available in 
respiratory medicine. However, it has been well known 
for many years that the development of disease-specific 
questionnaires is important to capture the patient- 
perceived quality of life correctly [8]. Recently, the 
Bronchiectasis Health Questionnaire (BHQ) was devel-
oped and validated in English. It is a brief question-
naire with ten items, each with a seven-point scoring 
range, that describes symptoms from the patient’s per-
spective and can be used in daily clinical practice [9]. 
The convergent validity of the BHQ score with the St 
George Respiratory Questionnaire (SGRQ) is high [9]. 
Furthermore, a clinical validation of the score was also 
undertaken in an English as well as an Asian popula-
tion. This validation found a significant association  
between the BHQ and disease exacerbations, hospital 
admissions, computed tomography scan bronchiectatic 
lobes and presence of bacterial colonisation [9]. 
Compared with previous HRQoL questionnaires, the 
BHQ has potential advantages as it is brief and provides 
a single score, although clinical experience with the 
BHQ still is limited. The BHQ has so far been translated 
and validated in eleven other languages [10], but not 
in Nordic languages.  
The aim of this study was to translate and validate 




The BHQ was translated from English into Danish. 
First, an in-depth analysis of the original BHQ English 
version (BHQE), (i.e., concept definition) was con-
ducted by two independent translators. This included 
suggestions of translation alternatives in Danish and a 
subsequent consensus between the two translators of 
the preliminary wording for the translation. Second, a 
pilot study was conducted. In the pilot, after complet-
ing the questionnaire, patients with bronchiectasis 
were interviewed about their understanding of the in-
dividual BHQ questions. A pre-defined interview guide 
was used for this purpose. Following this, a re-evalu-
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ation of the initial Danish version was made, and this 
version was reviewed by a clinician. Lastly, the revised 
version of the Danish BHQ questionnaire underwent 
forward/backward translation by a third translator.
Validation
Patients participating in the validation study of the 
BHQD were identified by specialist nurses from two spe-
cialised bronchiectasis clinics at a regional and a uni-
versity hospital in the Central and North Denmark Re-
gions. Patients included had previously been diagnosed 
with bronchiectasis with a diagnosis verified by high 
resolution computed tomography scans and clinical 
symptoms in terms of cough, sputum and recurrent 
lower airway infections. Only patients in stable state 
(i.e., no exacerbations six weeks prior to inclusion) 
were included in this study, and patients with ongoing 
non-tuberculous mycobacteria and fungal infections 
were not included. All patients were anonymised at 
baseline and asked to complete the BHQD (BHQD1) and 
SGRQ [11]. Every third patient was asked to perform 
the BHQD again after two weeks (BHQD2) and return it 
by mail. The BHQD2 was handed out to the patients in a 
stamped envelope, and the questionnaire was marked 
with their specific anonymised participant number.
Using IBM SPSS software, the convergent validity 
between the BHQD1 and the Danish St George’s 
Respiratory Questionnaire (SGRQ) [12] was investi-
gated with Spearman’s correlation coefficient. The in-
ternal consistency between BHQD1 and BHQD2 was 
tested with Cronbach’s alpha [13]. Agreement between 
the BHQD1 and the BHQD2 was assessed with a Bland-
Altman plot.
The study was presented to the local ethical com-
mittee, which found no need for ethical approval. 
Trial registration: not relevant.
ReSulTS
Translation
The in-depth analysis revealed no significant linguistic 
or cultural issues. The main difficulties consisted in 
finding conceptual equivalents in specific words, i.e. 
“anxiety”. Translators ensured that the continuity of 
time was kept between all versions using either adverbs 
or synonyms (e.g., “hele tiden” for “all of the time”).  
The pilot study on the initial version of the BHQD in-
cluded 17 patients with bronchiectasis. Based on the 
feedback from the interviews with the patients, items 
three and four were the most commonly debated for  
idiomatic or syntactic reasons. The re-evaluation 
proved useful to clarify the concept of “anxiety” in item 
three and led to changes in the wording. The forward/
backward translation revealed no discrepancies from 
the original version of the BHQE, and the final product 
of the linguistic validation was accepted as the BHQD. 
The final statements in the BHQD are demonstrated in 
Table 1. 
Validation
A total of 111 patients completed the BHQ at baseline 
(BHQD1). One third of those, 37 patients, were asked to 
complete the BHQ again after a fortnight (BHQD2), and 
22 patients returned a completed questionnaire. 
A scatter plot of the correlation between the BHQD1 
TABLE 1 / The final statements in the Danish Bronchiecta-
sis Health Questionnaire.
item no. Statement
  1 De sidste 14 dage har jeg været træt
  2 De sidste 14 dage har jeg været meget langsommere end 
mine jævnaldrende
  3 Inden for de sidste 14 dage har jeg følt mig ængstelig
  4 Indenfor de sidste 14 dage har jeg følt slim i brystet
  5 Inden for de sidste 14 dage har jeg følt mig flov på grund af 
hoste og opspyt
  6 Inden for de sidste 14 dage har jeg haft åndenød
  7 Inden for de sidste 14 dage har symptomerne fra mine 
 bronkiektasier forstyrret min søvn
  8 Inden for de sidste 14 dage har jeg haft hosteanfald
  9 Inden for de sidste 14 dage har jeg haft blod i opspyttet
10 Inden for de sidste 12 måneder har jeg fået antibiotika for 
 lungeinfektion
FIGURE 1 / Association between the St George Respiratory Questionaire (SGRQ) score 
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and the SGRQ is presented in Figure 1. Convergent  
validity between the BHQD1 and the SGRQ was high, 
Spearman’s correlation was –0,826 (p = 0.0001). Test-
retest reliability (repeatability) between the BHQD1 
and the BHQD2 was satisfactory [13], Cronbach’s alpha 
was 0,739. A mean difference of 2.30 was seen in the 
Bland-Altman plot with upper and lower limits of 
agreement of –15,96 and 20,56, respectively; and β = 
–3,749 (p = 0.799), demonstrated in Figure 2.
dISCuSSIon
HRQoL is significantly impaired in bronchiectasis. The 
BHQ has proved to be a brief, simple-to-use, disease-
specific health status measure providing a point-in-time 
picture of the patients’ quality of life. In addition, the 
BHQ guides the clinician in addressing the health-re-
lated problems that the patient may experience at a 
given point of time. The aim of this study was to trans-
late and validate the BHQ in Danish, the first Nordic 
version of this questionnaire.
The European Bronchiectasis Registry suggests use 
of the SGRQ in the evaluation of HrQoL in patients 
with bronchiectasis [14], and the SGRQ is also the most 
commonly used questionnaire in bronchiectasis pa-
tients [15]. In the present study, the BHQ was vali-
dated against the SGRQ, and a highly significant con-
vergent validity was demonstrated. Even though the 
SGRQ is well validated, widely used and specific for pa-
tients with pulmonary diseases, it is not disease spe-
cific. In the BHQE, a significant correlation with core 
symptoms in bronchiectasis was found. In other dis-
eases, disease-specific HRQoL questionnaires have 
been more sensitive in detecting disease changes, for 
better and for worse, and are more precise than generic 
HRQoL questionnaires [16, 17]. This still needs to be 
shown for the BHQ. However, the BHQ is brief and 
valid, so even as an equal to the SGRQ this may favour 
its use in daily clinical practice.
The BHQ has previously been translated into 11 lan-
guages using standardised methodology [10]. In con-
trast to previous BHQ translations, where items two, 
five and ten generated most discussion, items three and 
four were debated in the translational process into 
Danish, for idiomatic or syntactic reasons. Item 3, in 
particular, was reconsidered several times and changed 
in the final version after the pilot study in 17 patients. 
Danish and English are both Indo-European languages 
and both belong to the Germanic language family. 
Therefore, it may not be surprising that translation 
from English into Danish meets fewer language barri-
ers than for example translation from English into 
Mandarin. In item three, it was mainly the word “anx-
iety” that posed a translational problem. A previous 
study by Van Goozen et al. has, however, demonstrated 
that even within language families, emotion words do 
not translate easily [18]. Moreover, a recent semantic 
thesis debated that within the Indo-European lan-
guages, there are emotion words that do not translate 
at all [19]. It may therefore be surprising that item 
three has not previously been debated in the transla-
tional process.
The BHQD obtained a satisfactory repeatability. In 
the development of the BHQE, the questionnaire was 
highly repeatable after two weeks [9]. This brings us to 
the discussion of one of the limitations of this study, the 
relatively low return rate (60%) of the questionnaire 
after two weeks. This may have introduced some bias 
in our results. Hence, with a reduction in the number of 
participants, there is inevitably a loss of power in the 
analysis. Secondly, there is a risk that those who re-
turned the second questionnaire were the symptomatic 
patients. A change in symptoms could explain the satis-
factory repeatability. This may explain why repeatabil-
ity reached only a “satisfactory” and not the highest 
level. This hypothesis could also be supported by the 
Bland Altman analysis shown in Figure 2, which dem-
onstrates that three patients deviate considerably in 
agreement. In a small population, this may influence 
the results, not only of the repeatability but also the 
agreement between BHQD1 and BHQD2. However; a 
satisfactory repeatability is acceptable and as the in-
ternal validity of the BHQD is also good, this allows for 
use of the questionnaire in daily clinical practice. 
This study only performed linguistic validation of 
the BHQ. This may, of course, be a concern in relation 
to implementing the questionnaire in daily clinical 
practice. However, the BHQ has been developed and 
FIGURE 2 / Bland Altman plot used for the validation of the Danish Bronchiectasis He-
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validated in a British population very similar to the 
Danish population, and furthermore validated in an 
Asian population very different from the initial cohort. 
Therefore, the BHQ is considered to be clinically im-
placable in a Danish population when linguistically  
validated. However, it is important to underline that 
the BHQ is a tool to guide the health professionals in 
their contact with bronchiectasis patients and should 
not a substitute for doctor-patient contact.
Although the BHQ is clinically favourable compared 
to other HRQoL questionnaires, owing to its brevity 
and its disease specificity, which will highlight the pa-
tients’ perspective of the disease, it also has some short-
comings, not least due to its novelty. As such, no min-
imal clinically important difference (MCID) has been 
established. The simplicity of the BHQ may be a draw-
back, and large numbers will be needed when the 
MCID is to be established. However, if, in future, the in-
ventors of the score choose to establish an electronic 
version, the translation into several languages will be 
helpful in that respect. Furthermore, the BHQ has not 
been validated specifically in patients with severe 
chronic infections, and caution is therefore warranted 
if clinicians choose to use the BHQ in these patient sub-
groups. 
In conclusion, this study was the first translation 
and validation of the BHQ into Danish. The question-
naire has a highly convergent validity with the SGRQ 
which is recommended for use in bronchiectasis; how-
ever, the brevity of the BHQ may favour its use in daily 
clinical practice.
For the full version of the BHQD, please contact the 
developers of the English version [9].
CoRReSpondenCe: Ulla Møller Weinreich. E-mail: ulw@rn.dk
ACCepTed: 19 December 2019
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are available with the full text of this article at Ugeskriftet.dk/dmj
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